These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38413787)

  • 1. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
    Khardali A
    Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
    Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
    BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.
    Alghazwani Y; Alqahtani AM; Alshuraymi MK; Assiri IM; Shuflut AA; Krishnaraju V; Kumarappan C; Ibrahim ARN; Orayj K
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1667-1680. PubMed ID: 36876701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication safety knowledge, attitude, and practice among hospital pharmacists in tertiary care hospitals in Saudi Arabia: a multi-center study.
    Al-Mutairi A; AlFayyad I; Altannir Y; Al-Tannir M
    Arch Public Health; 2021 Jul; 79(1):130. PubMed ID: 34253257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
    Li R; Curtain C; Bereznicki L; Zaidi STR
    Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
    Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
    Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance Concept Knowledge, Perspectives and Attitudes: A Cross-Sectional Study Among Community Pharmacists.
    Abu Assab M; Alhamad H; Albahar F; Abu Dayyih W; Echarif S; Abu Assab H
    Inquiry; 2024; 61():469580241246464. PubMed ID: 38581250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitude and practice of hospital pharmacists towards pharmacovigilance and adverse drug reaction reporting in Najran, Saudi Arabia.
    Alshabi AM; Shaikh MAK; Shaikh IA; Alkahtani SA; Aljadaan A
    Saudi Pharm J; 2022 Jul; 30(7):1018-1026. PubMed ID: 35903528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
    Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.
    Shareef J; Sridhar SB; Bhupathyraaj M; Shariff A; Thomas S
    Ther Adv Drug Saf; 2024; 15():20420986241285930. PubMed ID: 39381061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study.
    Shkreli R; Dhamo K; Haloçi E; Tabaku A
    Pak J Pharm Sci; 2023 May; 36(3):713-721. PubMed ID: 37580918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.